Skip to main content
. 2019 Apr 9;3(3):420–423. doi: 10.1002/rth2.12201

Figure 1.

Figure 1

Immunosuppression course. R, rituximab; IVIG, intravenous immune globulin; AZA, azathioprine; M, mycophenolate; CS, corticosteroids; C, cyclophosphamide; tacro, tacrolimus; BU, Bethesda unit; cyclophosphamide: patient received oral low‐dose 8/7/2013‐11/27/2013 and 5/28/2015‐6/17/2015; intravenous high‐dose administration occurred 12/3/2013‐1/14/2014